CN103468733B - 抗猪圆环病毒2型的表达载体和转基因猪及其构建方法 - Google Patents
抗猪圆环病毒2型的表达载体和转基因猪及其构建方法 Download PDFInfo
- Publication number
- CN103468733B CN103468733B CN201310321355.6A CN201310321355A CN103468733B CN 103468733 B CN103468733 B CN 103468733B CN 201310321355 A CN201310321355 A CN 201310321355A CN 103468733 B CN103468733 B CN 103468733B
- Authority
- CN
- China
- Prior art keywords
- expression vector
- seqidno
- porcine circovirus
- egfp
- neo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241001673669 Porcine circovirus 2 Species 0.000 title claims abstract description 69
- 230000009261 transgenic effect Effects 0.000 title claims abstract description 64
- 238000000034 method Methods 0.000 title claims abstract description 49
- 239000013604 expression vector Substances 0.000 title claims abstract description 43
- 238000010276 construction Methods 0.000 title claims abstract description 23
- 230000008569 process Effects 0.000 title claims abstract description 22
- 239000013612 plasmid Substances 0.000 claims abstract description 57
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 35
- 108010048367 enhanced green fluorescent protein Proteins 0.000 claims abstract description 31
- 230000004927 fusion Effects 0.000 claims abstract description 23
- 239000012634 fragment Substances 0.000 claims abstract description 16
- 210000004027 cell Anatomy 0.000 claims description 39
- 238000012408 PCR amplification Methods 0.000 claims description 24
- 238000002156 mixing Methods 0.000 claims description 22
- 210000000287 oocyte Anatomy 0.000 claims description 14
- 239000004055 small Interfering RNA Substances 0.000 claims description 14
- 108091027967 Small hairpin RNA Proteins 0.000 claims description 13
- 210000001161 mammalian embryo Anatomy 0.000 claims description 13
- 230000004087 circulation Effects 0.000 claims description 12
- 230000004044 response Effects 0.000 claims description 12
- 102000008579 Transposases Human genes 0.000 claims description 11
- 108010020764 Transposases Proteins 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- 238000012216 screening Methods 0.000 claims description 10
- 238000001890 transfection Methods 0.000 claims description 9
- 238000009395 breeding Methods 0.000 claims description 6
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- 150000002367 halogens Chemical class 0.000 claims description 6
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- 239000002356 single layer Substances 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 5
- 210000002966 serum Anatomy 0.000 claims description 5
- 244000309466 calf Species 0.000 claims description 4
- 230000010261 cell growth Effects 0.000 claims description 4
- 210000003754 fetus Anatomy 0.000 claims description 4
- 210000002950 fibroblast Anatomy 0.000 claims description 4
- 239000001963 growth medium Substances 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 3
- 241001045988 Neogene Species 0.000 claims description 3
- 101150091879 neo gene Proteins 0.000 claims description 3
- 108020004459 Small interfering RNA Proteins 0.000 abstract description 15
- 230000015572 biosynthetic process Effects 0.000 abstract description 6
- 230000010354 integration Effects 0.000 abstract description 6
- 238000003786 synthesis reaction Methods 0.000 abstract description 6
- 208000015181 infectious disease Diseases 0.000 abstract description 5
- 108700019146 Transgenes Proteins 0.000 abstract description 4
- 239000013598 vector Substances 0.000 abstract description 3
- 238000004088 simulation Methods 0.000 abstract description 2
- 238000010374 somatic cell nuclear transfer Methods 0.000 abstract description 2
- 241000282898 Sus scrofa Species 0.000 description 64
- 108020004414 DNA Proteins 0.000 description 15
- 102000004190 Enzymes Human genes 0.000 description 14
- 108090000790 Enzymes Proteins 0.000 description 14
- 241000700605 Viruses Species 0.000 description 11
- 238000012797 qualification Methods 0.000 description 11
- 238000013461 design Methods 0.000 description 9
- 230000029087 digestion Effects 0.000 description 8
- 238000002105 Southern blotting Methods 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108091008146 restriction endonucleases Proteins 0.000 description 7
- 108700026244 Open Reading Frames Proteins 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000009368 gene silencing by RNA Effects 0.000 description 6
- 108091030071 RNAI Proteins 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 210000004508 polar body Anatomy 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000003101 oviduct Anatomy 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 229960005486 vaccine Drugs 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 description 3
- 101710130262 Probable Vpr-like protein Proteins 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 230000035800 maturation Effects 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 238000007857 nested PCR Methods 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 101150044789 Cap gene Proteins 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 108010042407 Endonucleases Proteins 0.000 description 2
- 102000004533 Endonucleases Human genes 0.000 description 2
- 101000833492 Homo sapiens Jouberin Proteins 0.000 description 2
- 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 2
- 102100024407 Jouberin Human genes 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229940031551 inactivated vaccine Drugs 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002611 ovarian Effects 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000000384 rearing effect Effects 0.000 description 2
- 101150066583 rep gene Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 230000029812 viral genome replication Effects 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 101100140610 Porcine circovirus 2 Rep gene Proteins 0.000 description 1
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 1
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- CWHJIJJSDGEHNS-MYLFLSLOSA-N Senegenin Chemical compound C1[C@H](O)[C@H](O)[C@@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)C(CC[C@]4(CCC(C[C@H]44)(C)C)C(O)=O)=C4[C@@H](CCl)C[C@@H]3[C@]21C CWHJIJJSDGEHNS-MYLFLSLOSA-N 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 238000011217 control strategy Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000008175 fetal development Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 210000002503 granulosa cell Anatomy 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 208000018875 hypoxemia Diseases 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000002394 ovarian follicle Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000008684 selective degradation Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229940031626 subunit vaccine Drugs 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000009871 tenuigenin Substances 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310321355.6A CN103468733B (zh) | 2013-07-26 | 2013-07-26 | 抗猪圆环病毒2型的表达载体和转基因猪及其构建方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310321355.6A CN103468733B (zh) | 2013-07-26 | 2013-07-26 | 抗猪圆环病毒2型的表达载体和转基因猪及其构建方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103468733A CN103468733A (zh) | 2013-12-25 |
CN103468733B true CN103468733B (zh) | 2016-01-27 |
Family
ID=49793774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310321355.6A Expired - Fee Related CN103468733B (zh) | 2013-07-26 | 2013-07-26 | 抗猪圆环病毒2型的表达载体和转基因猪及其构建方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103468733B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103710386B (zh) * | 2013-12-26 | 2016-04-06 | 华南农业大学 | 转基因动物的制备方法 |
CN106609283A (zh) * | 2015-10-26 | 2017-05-03 | 潘雨堃 | 一种利用转座子进行多基因同时操作的方法 |
CN107177630A (zh) * | 2017-05-09 | 2017-09-19 | 华南农业大学 | 一种无外源标记基因的抗pcv2转基因猪制备方法 |
CN107018955A (zh) * | 2017-05-09 | 2017-08-08 | 华南农业大学 | 一种抗猪圆环病毒2型的转基因猪 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101659953A (zh) * | 2009-09-10 | 2010-03-03 | 浙江大学 | 抗猪圆环病毒病shRNA及其设计合成法和用途 |
WO2011005793A1 (en) * | 2009-07-06 | 2011-01-13 | Alnylam Pharmaceuticals, Inc. | Cell-based bioprocessing |
CN102851311A (zh) * | 2012-02-24 | 2013-01-02 | 浙江大学 | 一种抗猪圆环病毒2型病转基因猪的构建方法 |
-
2013
- 2013-07-26 CN CN201310321355.6A patent/CN103468733B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011005793A1 (en) * | 2009-07-06 | 2011-01-13 | Alnylam Pharmaceuticals, Inc. | Cell-based bioprocessing |
CN101659953A (zh) * | 2009-09-10 | 2010-03-03 | 浙江大学 | 抗猪圆环病毒病shRNA及其设计合成法和用途 |
CN102851311A (zh) * | 2012-02-24 | 2013-01-02 | 浙江大学 | 一种抗猪圆环病毒2型病转基因猪的构建方法 |
Non-Patent Citations (4)
Title |
---|
Inhibition of porcine circovirus type 1 and type 2 production in PK-15 cells by small interfering RNAs targeting the Rep gene;Minxuan Sun等;《Veterinary Microbiology》;20071231;第123卷;203-209 * |
Replication efficiency of rolling-circle replicon-based plasmids derived from porcine circovirus 2 in eukaryotic cells;Florence Faurez等;《Journal of Virological Methods》;20101231;第165卷;27-35 * |
基于质粒表达的siRNA对猪圆环病毒2型(PCV2)复制的抑制作用;李曼 等;《农业生物技术学报》;20111231;第19卷(第3期);513-520 * |
载体表达的siRNA分子对猪圆环病毒2型复制的抑制作用;王海燕 等;《微生物学报》;20081104;第48卷(第11期);1507-1513 * |
Also Published As
Publication number | Publication date |
---|---|
CN103468733A (zh) | 2013-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109439634B (zh) | 伪狂犬病病毒基因工程弱毒疫苗株及其应用 | |
CN103468733B (zh) | 抗猪圆环病毒2型的表达载体和转基因猪及其构建方法 | |
CN107815441A (zh) | 一种ⅱ型伪狂犬病毒减毒株及其制备方法和应用 | |
CN101665781B (zh) | 高滴度猪圆环病毒2型培养细胞、制备方法及其用法 | |
CN102614507B (zh) | 一种o型***分子标记疫苗及其制备方法 | |
CN104419719B (zh) | 一种转基因猪筛选标记基因敲除的方法 | |
CN102363769B (zh) | 鸡马立克氏病毒Meq基因缺失疫苗株,其构建方法及应用 | |
CN108384762B (zh) | 猪α肠道冠状病毒及其培养方法和应用 | |
CN109402145B (zh) | 一种免疫增强型重组prrsv病毒样颗粒亚单位疫苗的制备方法 | |
CN104195116B (zh) | 一种表达鹅细小病毒vp3基因的重组新城疫病毒及其构建方法 | |
CN111926037A (zh) | 一种利用双sgRNA技术敲除MSTN基因的质粒及敲除MSTN基因的方法 | |
CN103468732A (zh) | piggyBac转座子表达载体和转基因猪及其构建方法 | |
CN105039342A (zh) | 能抑制MAT2A基因表达的siRNA及其应用 | |
CN101401937A (zh) | 共表达prrsv orf5及orf6双基因核酸疫苗的制备方法 | |
CN109207577B (zh) | Marco在筛选抗蓝耳病猪中的应用 | |
CN102965345B (zh) | 猪细小病毒、疫苗组合物及其应用 | |
CN115141273B (zh) | 一种猫杯状病毒的单克隆抗体及其应用 | |
CN110496222A (zh) | 人ncaph基因的用途 | |
CN104726409B (zh) | 一种永生化的鸭胚肝细胞系的制备方法和应用 | |
CN102899293A (zh) | 促血管生成素1基因修饰的间充质干细胞、及其构建方法与应用 | |
CN107029231B (zh) | 重组***二价灭活疫苗及其制备方法和应用 | |
CN102703506A (zh) | α1,2-岩藻糖转移酶基因沉默的体细胞克隆猪及其生产方法与应用 | |
CN107018955A (zh) | 一种抗猪圆环病毒2型的转基因猪 | |
CN105238764A (zh) | 一种伪狂犬病毒LLT区ΔIntron株及构建方法和应用 | |
CN102247606B (zh) | 一种基于dna水平的高致病性猪蓝耳病病毒jev复制子疫苗及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: LI ZICONG Effective date: 20150128 Owner name: SOUTH CHINA AGRICULTURAL UNIVERSITY Free format text: FORMER OWNER: WU ZHENFANG Effective date: 20150128 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Wu Zhenfang Inventor after: Li Zicong Inventor after: Xu Zhiqian Inventor after: Zou Xian Inventor after: Zhang Xianwei Inventor after: He Xiaoyan Inventor after: Shi Junsong Inventor after: Liu Dewu Inventor before: Xu Zhiqian Inventor before: Zou Xian Inventor before: Zhang Xianwei Inventor before: He Xiaoyan Inventor before: Shi Junsong Inventor before: Liu Dewu Inventor before: Li Zicong Inventor before: Wu Zhenfang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: XU ZHIQIAN ZOU XIAN ZHANG XIANWEI HE XIAOYAN SHI JUNSONG LIU DEWU LI ZICONG WU ZHENFANG TO: WU ZHENFANG LI ZICONG XU ZHIQIAN ZOU XIAN ZHANG XIANWEI HE XIAOYAN SHI JUNSONG LIU DEWU |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150128 Address after: 510642 new building of College of animal science, South China Agricultural University, Guangzhou, Guangdong, Tianhe District Applicant after: SOUTH CHINA AGRICULTURAL University Address before: 510642 new building of College of animal science, South China Agricultural University, Guangzhou, Guangdong, Tianhe District Applicant before: Wu Zhenfang Applicant before: Li Zicong |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160127 Termination date: 20210726 |
|
CF01 | Termination of patent right due to non-payment of annual fee |